CTA1-DD vaccine adjuvant (Biovitrum)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCTA1-DD vaccine adjuvant (Biovitrum)
Drug Alias Namecholera toxin A1-based gene fusion protein (Biovitrum)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVaccination
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSwedish Orphan Biovitrum Ab (Publ)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSwedish Orphan Biovitrum Ab (Publ)
Active IndicationsN/A
Inactive IndicationsVaccination

Other Information

ATC CodeN/A
Related LinksN/A